MTVA

MetaVia Inc.
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$19.88M
P/E Ratio
EPS
$-4.21
Beta
0.58
52W High
$19.03
52W Low
$0.97
50-Day MA
$1.48
200-Day MA
$5.82
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About MetaVia Inc.

MetaVia Inc. is an innovative technology company renowned for its advanced digital solutions that enhance connectivity and productivity across diverse industries. Leveraging cutting-edge artificial intelligence and cloud computing technologies, the company offers robust platforms tailored to meet the specific needs of its clients. Committed to sustainability and social responsibility, MetaVia not only aligns with contemporary market demands but also lays the groundwork for sustained growth. With a strategic emphasis on adaptability and collaboration, the company is poised to seize emerging opportunities within the dynamic tech landscape, thereby generating significant value for its shareholders.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)0
EBITDA$-13.83M
Operating Margin0.00%
Return on Equity-195.10%
Return on Assets-65.30%
Revenue/Share (TTM)$0.00
Book Value$2.31
Price-to-Book2.19
Price-to-Sales (TTM)
EV/Revenue-
EV/EBITDA-0.43
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$5.16M
Float$3.39M
% Insiders34.50%
% Institutions13.38%

Historical Volatility

HV 10-Day
161.36%
HV 20-Day
122.32%
HV 30-Day
117.76%
HV 60-Day
94.77%
HV Rank

Volatility is currently expanding

Analyst Ratings

Consensus ($19.33 target)
1
Strong Buy
1
Buy

More HEALTHCARE Stocks

Data last updated: 5/25/2026